Prostatectomy postoperative urinary incontinence: From origin to treatment

IF 0.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Precision Medical Sciences Pub Date : 2023-12-01 DOI:10.1002/prm2.12121
Quan Jing, Jijia Gu, Ziwei Li, Xuan Sun, Qiuyang Chen, Shanhong Li, Weizhang Xu
{"title":"Prostatectomy postoperative urinary incontinence: From origin to treatment","authors":"Quan Jing, Jijia Gu, Ziwei Li, Xuan Sun, Qiuyang Chen, Shanhong Li, Weizhang Xu","doi":"10.1002/prm2.12121","DOIUrl":null,"url":null,"abstract":"Prostate cancer is a common malignant tumor at present, and there are still adverse reactions after radical prostatectomy. As many as 30% of patients complain of urinary incontinence (UI). This review begins with the pathophysiological basis of post‐prostatectomy urinary incontinence (PPUI) and describes the maintenance of normal urine control function, anatomical changes, and urodynamic maintenance of PPUI. Then, we talk about the various influencing factors of UI, for example, the differences caused by the basic condition of the patient, the length of the membranous urinary tract, the level of prostate‐specific antigen before operation, the method and technique of operation, and so on. Last, we introduce all kinds of treatments of PPUI in detail. It includes noninvasive conservative treatment, traditional surgical treatment, emerging stem cell therapy treatment, and postoperative psychotherapy of PPUI. The present situation of the treatment of UI after prostatectomy is summarized, and the prospect of the technology is put forward.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"384 3","pages":"224 - 232"},"PeriodicalIF":0.4000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Precision Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/prm2.12121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Prostate cancer is a common malignant tumor at present, and there are still adverse reactions after radical prostatectomy. As many as 30% of patients complain of urinary incontinence (UI). This review begins with the pathophysiological basis of post‐prostatectomy urinary incontinence (PPUI) and describes the maintenance of normal urine control function, anatomical changes, and urodynamic maintenance of PPUI. Then, we talk about the various influencing factors of UI, for example, the differences caused by the basic condition of the patient, the length of the membranous urinary tract, the level of prostate‐specific antigen before operation, the method and technique of operation, and so on. Last, we introduce all kinds of treatments of PPUI in detail. It includes noninvasive conservative treatment, traditional surgical treatment, emerging stem cell therapy treatment, and postoperative psychotherapy of PPUI. The present situation of the treatment of UI after prostatectomy is summarized, and the prospect of the technology is put forward.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
前列腺切除术后尿失禁:从起源到治疗
前列腺癌是目前常见的恶性肿瘤,根治性前列腺切除术后仍存在不良反应。多达 30% 的患者抱怨尿失禁(UI)。本综述从前列腺切除术后尿失禁(PPUI)的病理生理基础入手,介绍了PPUI的正常尿控功能维持、解剖学变化和尿动力学维持。然后,介绍尿失禁的各种影响因素,如患者的基础条件、膜尿道长度、术前前列腺特异性抗原水平、手术方法和技术等造成的差异。最后,我们将详细介绍 PPUI 的各种治疗方法。其中包括 PPUI 的无创保守治疗、传统手术治疗、新兴的干细胞治疗以及术后心理治疗。总结了前列腺切除术后尿路感染的治疗现状,并提出了该技术的发展前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Precision Medical Sciences
Precision Medical Sciences MEDICINE, RESEARCH & EXPERIMENTAL-
自引率
0.00%
发文量
33
审稿时长
15 weeks
期刊最新文献
Prostatectomy postoperative urinary incontinence: From origin to treatment A case report of adult type 2 familial hemophagocytic lymphohistiocytosis Which inflammatory marker might be the best indicator for sacroiliitis? miRNAs involvement in the etiology and targeted therapy of bladder cancer: Interaction between signaling pathway Xiaotan Sanjie Fang prevents colonic inflammation‐related tumorigenesis by inhibiting COX‐2/VEGF expression cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1